To this effect, our group has previously investigated the role of C5a/C5aR in a mouse model of IBD, dextran sulfate sodium (DSS)-induced colitis, and found that targeted deletion of C5aR is protective in acute but disadvantageous in chronic colitis [12]. Here, C5AR1 is linked to inflammatory bowel disease.